Login / Signup

Efficacy of zinc supplementation for the treatment of dysmenorrhoea: a double-blind randomised controlled trial.

Hillary I ObiagwuGeorge Uchenna ElejeNworah J A ObiechinaBetrand O NwosuGerald O UdigweJoseph I IkechebeluJoseph O UgboajaChukwuemeka C OkoroIfeanyi O OkonkwoAyodele O OkwuosaCharlotte B OguejioforChisom G ChigboChukwudi A OgabidoChidinma Charity OkaforChigozie Geoffrey Okafor
Published in: The Journal of international medical research (2023)
Zinc sulfate reduces dysmenorrhoea severity with minimal or no adverse effects, especially with more than one cycle of usage.Trial Registration Number: PACTR202105843292338. The trial is publicly available and was registered at www.pactr.org on 25 May 2021.
Keyphrases
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • oxide nanoparticles
  • randomized controlled trial
  • open label
  • double blind
  • placebo controlled
  • combination therapy